Rajat Bhatt, MD
Rheumatology · Richmond, TXNPI 1013938349
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,013 and has fallen 76.4% since, to $239 in 2025. That places this record below the midpoint for rheumatology clinicians in TX, where the typical reported total is $3,779.
Across 181 payments — averaging $23.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$850
- Lilly USA, LLC$485
- Amgen$445
- UCB, Inc.$289
- Fidia Pharma USA Inc.$249
- AstraZeneca$198
- plus $2K from 26 others
Across 29 payments — averaging $4323.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$57K
- Eli Lilly$34K
- UCB SA$26K
- E.r. Squibb & Sons, L.L.C.$6K
- Mitsubishi Tanabe Pharma Development America, Inc.$3K
What the payments were for
- Food & beverage$4,277100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $850 |
| Lilly USA, LLC | 25 | $485 |
| Amgen(2 entities) | 23 | $445 |
| UCB, Inc. | 9 | $289 |
| Fidia Pharma USA Inc. | 20 | $249 |
| AstraZeneca(2 entities) | 11 | $198 |
| E.r. Squibb & Sons, L.L.C. | 4 | $185 |
| Johnson & Johnson | 8 | $169 |
| GSK | 8 | $132 |
| Organogenesis Inc. | 2 | $129 |
| Abbott | 1 | $127 |
| Boehringer Ingelheim | 4 | $100 |
| Silk Road Medical, Inc. | 1 | $97 |
| Paratek Pharmaceuticals, Inc. | 1 | $96 |
| Pfizer | 5 | $93 |
| Pulmonx Corporation | 1 | $92 |
| Impulse Dynamics (USA) Inc. | 1 | $87 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $74 |
| Octapharma USA, Inc. | 1 | $51 |
| Ultragenyx Pharmaceutical Inc. | 2 | $46 |
| Bristol Myers Squibb | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Cumberland Pharmaceuticals, Inc. | 2 | $26 |
| Radius Health, Inc. | 1 | $25 |
| Novartis | 1 | $22 |
| Oxford Immunotec USA Inc | 1 | $21 |
| Insulet Corporation | 1 | $21 |
| Sanofi | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mitra Clip system$127
- Humira$125
- ELIQUIS$124
- Cimzia$120
How this compares
$4,285 in reported general payments places this provider in the 50th percentile of 512 rheumatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 19 | $127,197 |
| Celecoxib | 103 | $3,884 |
| Hydroxychloroquine Sulfate | 97 | $2,059 |
| MethotrexateMethotrexate Sodium | 86 | $1,194 |
| Diclofenac Sodium | 14 | $404 |
| Alendronate Sodium | 52 | $263 |
| Tramadol Hcl | 32 | $179 |
| Prednisone | 19 | $158 |
| Naproxen | 16 | $146 |
| Folic Acid | 23 | $133 |
| Duloxetine Hcl | 12 | $109 |
| Allopurinol | 16 | $78 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Richmond
- John CushDallas$3.7M
- Sanjay ChabraEl Paso$3.3M
- Dhiman BasuColleyville$1.8M
- Frank WellborneNew Braunfels$1.4M
- Christopher ParkerWest Lake Hills$1.4M
- Pendleton WickershamSan Antonio$954K
- Henry TownsendPlano$738K
- Zoran KurepaDallas$483K
- Giovanni GeslaniDallas$415K
- Dianne PetroneDallas$401K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.